Outpatient Parenteral Antimicrobial Therapy Outcomes Metrics Assessment Survey

2025/04/28 by Jina Makadia, Amber C Streifel, Cara D Varley · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Antibiotic Use and Resistance #Antibiotics Pharmacokinetics and Efficacy #Bacterial Identification and Susceptibility Testing

paper · pdf · doi:10.1093/ofid/ofaf283

openalex publication_date 2025/04/28 · openalex created_date 2025/05/12 · openalex updated_date 2026/07/30

Abstract

We surveyed outpatient parenteral antimicrobial therapy team members to assess the importance of specific program metrics while eliciting collection barriers, which can guide establishing or restructuring programs. Several metrics were felt to be highly important but were not being collected by programs. Identified barriers included a lack of funding, technology support, and staffing.

Citations

• Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015–19)

Cited by

• 2026 Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK

Discussions

• Outpatient Parenteral Antimicrobial Therapy (OPAT) Outcomes Metrics Assessment Survey ✅ Just Accepted ⭐ Editor's Choice #IDSky [bsky, 1 points, 0 comments]

Related

• Management of outpatient parenteral antibiotic therapy: a United States-based multi-center survey
• Outpatient parenteral antimicrobial therapy delivery, readmission rates, and multidisciplinary teams: a scoping review of the impact of published quality indicators
• Propensity Score–Weighted Analysis of the Impact of Outpatient Parenteral Antimicrobial Therapy Plan Reconciliation on Unscheduled Care
• Quantifying and Financing the Nonbillable Workload of Outpatient Parenteral Antimicrobial Therapy (OPAT)—A Model for Assessing and Supporting Staffing Needs for OPAT Programs
• Rates of line associated bloodstream infections in self-administered outpatient parenteral antimicrobial therapy compared to standard of care: 11 years of data at a safety net hospital